drugset / Trial / NCT02314793
A Study to Assess the Safety, Tolerability and Pharmacokinetics of ASP2205 in Healthy Young Males and Females and Elderly Females and to Evaluate the Effect of Food on the Pharmacokinetics of a Single Dose of of ASP2205
RandomizedParallel-groupDouble-blindBasic science
Summary
The purpose of this study is to evaluate the safety and tolerability of single ascending oral doses of ASP2205 in healthy young male and female subjects. This study will also evaluate the safety and tolerability of multiple ascending oral doses of ASP2205 in healthy young and elderly female subjects.
Timeline
- Start
- 2014-11
- Primary completion
- 2015-10
- Completion
- 2015-10
Outcome
Outcome not reported
Stopped: “The study has been terminated because of operational reasons.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ASP2205 | Small molecule | — | Oral |
Indications
No indication recorded.